Instill Bio trading halted, volatility trading pause
PremiumThe FlyInstill Bio trading halted, volatility trading pause
7d ago
Instil Bio price target raised to $40 from $25 at H.C. Wainwright
Premium
The Fly
Instil Bio price target raised to $40 from $25 at H.C. Wainwright
8d ago
Instil Bio price target raised to $25 from $18 at H.C. Wainwright
Premium
The Fly
Instil Bio price target raised to $25 from $18 at H.C. Wainwright
28d ago
Instil Bio, ImmuneOnco announce license, collaboration pact for IMM2510
PremiumThe FlyInstil Bio, ImmuneOnco announce license, collaboration pact for IMM2510
2M ago
Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody
Premium
Press Releases
Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody
2M ago
One new option listing and eighteen option delistings on July 22nd
Premium
The Fly
One new option listing and eighteen option delistings on July 22nd
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100